Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease

Abstract

Dysregulation of eEF1A and its associated signaling pathways might represent novel molecular mechanisms underlying AD pathogenesis. Further investigation is necessary to determine whether eEF1A is a viable therapeutic target for AD and other cognitive syndromes.